Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing increased scrutiny ...
Biophysicists have developed a method for modifying the surface of micro- and nanoparticles—tiny structures measuring between a thousandth and a millionth of a millimeter —by covering them with biological molecules. Engineered ...
A Sandia National Laboratories team has designed and synthesized nanoparticles that glow red and are stable, useful properties for tracking cancer growth and spread.
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
EPFL researchers have used electrochemical imaging to take a step forward in mapping the distribution of biomolecules in tissue. This technology, which uses only endogenous markers – rather than contrast agents – could ...
Although the most basic definition of a "theranostic" nanoparticle is a nanoparticle that simply has a therapeutic moiety and imaging or diagnostic moiety on the same particle, the authors of a new SLAS Technology review ...
Researchers at ITMO University unveiled a new approach for printing luminescent structures based on nanoparticle ink. The unique optical properties of the ink were achieved by means of europium-doped zirconia. Particles of ...
An international team in which a UPM researcher is involved has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.
Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective. Now, American scientists have developed a hybrid nanomaterial that releases a ...
Chemists at the University of Alabama at Birmingham have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.
